 Connection
Thomas Morrison to Viremia
This is a "connection" page, showing publications Thomas Morrison has written about Viremia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.053 |
|
|
|
-
Ander SE, Davenport BJ, Evans AB, Morrison TE. Systemic Clodronate Liposome Treatment for Depletion of Blood-Contacting Phagocytes and Investigation of Their Role in the Control of Bunyavirus Viremia. Methods Mol Biol. 2025; 2893:285-298.
Score: 0.859
-
Carpentier KS, Sheridan RM, Lucas CJ, Davenport BJ, Li FS, Lucas ED, McCarthy MK, Reynoso GV, May NA, Tamburini BAJ, Hesselberth JR, Hickman HD, Morrison TE. MARCO+ lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination. EMBO J. 2021 11 15; 40(22):e108966.
Score: 0.687
-
Ander SE, Fish ER, da Silva MOL, Davenport BJ, Parks MG, Morrison TE. Basic patches on the E2 glycoprotein of eastern equine encephalitis virus influence viral vascular clearance and dissemination in mice. J Virol. 2025 Jun 17; 99(6):e0060225.
Score: 0.221
-
Li FS, Carpentier KS, Hawman DW, Lucas CJ, Ander SE, Feldmann H, Morrison TE. Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia. Cell Rep. 2023 05 30; 42(5):112418.
Score: 0.191
-
Jupille HJ, Medina-Rivera M, Hawman DW, Oko L, Morrison TE. A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts. J Virol. 2013 May; 87(10):5970-84.
Score: 0.095
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|